Management

Executive Officers 

Patrick Balthrop

Patrick J. Balthrop Sr.
President and Chief Executive Officer

Mr. Balthrop joined Luminex in May 2004 as President and Chief Executive Officer and has served as a member of the board of directors since September 2004. He served as president of Fisher Healthcare, a Fisher Scientific International company, a manufacturer and supplier of products and services principally to the scientific and laboratory markets from 2002 to May 2004. Prior to Fisher Scientific International, Mr. Balthrop served in a number of leadership positions for over 20 years with Abbott Laboratories, a global, broad-based health care company, primarily in Abbott’s Diagnostics Division. Mr. Balthrop’s most recent positions at Abbott were as head of worldwide commercial diagnostics operations and as head of Abbott Vascular. Mr. Balthrop holds an M.B.A. from the Kellogg Graduate School of Management of Northwestern University, and a B.S. in Biology from Spring Hill College.

Harriss Currie

Harriss T. Currie
Chief Financial Officer, Senior Vice President, Finance and Treasurer

Mr. Currie was elected as the VP, Finance, Treasurer and Chief Financial Officer in October of 2003. Since joining the company in November of 1998, Mr. Currie served in the capacities of Controller, Treasurer and Acting Chief Financial Officer. Prior to joining Luminex, he was employed as the Chief Financial Officer, Secretary and Treasurer of SpectraCell Laboratories from 1993 to 1998 where he also served as Vice President of Finance for two subsidiary companies. Mr. Currie earned his B.B.A. from Southwestern University in 1986 and his M.B.A. in Finance and Marketing from The University of Texas at Austin in 1992. Prior to returning to school for his M.B.A., Mr. Currie was a certified public accountant with Deloitte & Touche LLP.

Jeremy Bridge-Cook

Jeremy Bridge-Cook, Ph.D.
Senior Vice President, Research and Development

Dr. Bridge-Cook was named Senior Vice President of Research and Development in May 2012. Previously he served as Senior Vice President of the Assay Group and Vice President, Luminex Molecular Diagnostics. He also served at Tm Bioscience, which became Luminex Molecular Diagnostics following the acquisition of Tm Bioscience by Luminex in March 2007. Dr. Bridge-Cook joined Tm Bioscience in July 2000 as Director of Business Development and served in various capacities thereafter, including Vice President of Business Development, Vice President of Marketing & Business Development, and Senior Vice President of Corporate Development. Prior to joining Tm, Dr. Bridge-Cook worked as a venture capital investment analyst at MDS Capital Corporation and University Medical Discoveries Inc. Dr. Bridge-Cook has a Ph.D. in immunology from the University of Toronto.

Mike Pintek
 

Michael F. Pintek
Senior Vice President, Operations

Mr. Pintek joined Luminex Corporation as Senior Vice President of Operations in July of 2009. He joined Luminex from Roche, where he held several positions of increasing responsibility since 2001, most recently as Vice President and General Manager, Blood Screening, Roche Molecular Systems. Prior to Roche, his experience includes positions with Ventana Medical Systems and Abbott Laboratories’ Diagnostics Division. Mr. Pintek holds a B.S. in Business Administration from Central Michigan University.

Russell Bradley
 

Russell W. Bradley
Senior Vice President, Corporate Development and Global Marketing

Mr. Bradley joined Luminex Corporation in May 2005 as Vice President of Business Development and Strategic Planning. Previously, Mr. Bradley spent 17 years at Beckman Coulter Corp., a manufacturer of biomedical testing systems and products, where he served in roles of increasing responsibility in global commercial operations and, most recently as the director of the Beckman Coulter CARES initiative, responsible for Beckman Coulter’s clinical HIV/AIDS monitoring. During his tenure at Beckman Coulter, Mr. Bradley was involved in the evaluation, market assessment and successful commercial launch of multiple life science technologies. Mr. Bradley holds a B.S. in Immunology and Biochemistry from Monash University, Melbourne, Australia.

David Reiter

David S. Reiter
Senior Vice President, General Counsel and Corporate Secretary

Mr. Reiter has served as the Company’s Vice-President, General Counsel and Corporate Secretary since October 2003. Prior to becoming General Counsel for Luminex, Mr. Reiter was in private practice with the firm of Phillips & Reiter, PLLC, which provides outsourced general counsel services for small to medium market technology companies. Before co-founding his own firm, Mr. Reiter was Vice President and General Counsel for 724 Solutions Inc., a provider of mobile commerce software solutions and applications (NASDAQ: SVNX). Earlier in his career, Mr. Reiter served as senior counsel for Compaq Computer Corporation, supporting the Worldwide Sales & Services, Supply Chain Management and Consumer Products Group during his tenure. Mr. Reiter is a graduate of the University of Southern California (JD/MIR), University of Sheffield, UK (MBA) and the University of Notre Dame (BA). Mr. Reiter is a member of the Texas Bar and the American Bar Association and is on the Board of Directors for the Austin Chamber of Commerce.

  

Management Team

Amy Altman

Amy L. Altman, Ph.D.
Vice President, Biodefense

Dr. Altman was appointed Vice President, Biodefense on July 1, 2010. Dr. Altman joined Luminex in March, 2007, and has served as Director of the Extramural Research Office and most recently as Senior Director of Research and Development for the Luminex Bioscience Group. Prior to joining Luminex, Dr. Altman was an Associate with Booz Allen Hamilton, where she focused on Chemical and Biological Defense and technology development. Dr. Altman earned her B.A. degree in Microbiology in 1993 and her M.S. degree in Microbiology in 1996 from Miami University. Dr. Altman earned her Ph.D. in Molecular Biology from Vanderbilt University in 2000.

Steve Back

Steven Back
Vice President, Manufacturing and Quality Surveillance

Mr. Back joined Luminex Corporation as Vice President of Manufacturing in June of 2008. Prior to joining Luminex, Mr. Back was employed for 18 years at Abbott Laboratories Diagnostic Division in Dallas. While at Abbott, he held various management and technical positions in Manufacturing Operations, Technical Product Development and Quality. Prior to joining Abbott Laboratories, he was a Test Development Engineer for General Dynamics in Ft. Worth Texas. Mr. Back graduated from Wright State University in 1984 with a B.S. degree in Systems Engineering and holds an M.S.E.E degree from the University of Texas at Arlington as well as a M.B.A. from the University of Dallas.

Nancy Capezzuti

Nancy M. Fairchild, SPHR
Vice President, Human Resources
Mrs. Fairchild joined Luminex in March of 2010 as the Senior Director of Human Resources and was promoted to Vice President, Human Resources in August 2012. She previously served as Chief Administrative Officer and Vice President of Human Resources and Organizational Development for the Electric Reliability Council of Texas (ERCOT). Prior to ERCOT, Mrs. Fairchild served as Vice President Human Resources for Esoterix, Inc., an international healthcare company specializing in laboratory services. Mrs. Fairchild is currently a member of the Board of Directors for Workforce Solutions, representing the biotech sector. She graduated with honors from Texas State University with a B.S. degree in Math Education and a Master’s degree in Counseling. 

 Chuck Collins

Charles J. Collins, Ph.D.
Vice President, Systems Research and Development

Dr. Collins joined Luminex Corporation in 2006 and was named Vice President of Systems Research and Development in May 2012.  During his tenure Dr. Collins has held increasing leadership positions most recently as Senior Director of the Advanced Technology Group.  As a recognized expert with over 35 publications in the field of engineering, Dr. Collins led the successful development of the MAGPIX instrument.  Prior to joining Luminex, Dr. Collins conducted research at the University of Texas at Austin and the U.S. Army Research Laboratory.  Dr. Collins earned his Ph.D. in solid state electronics from the University of Texas at Austin.

Tom Copa

Thomas J. Copa
Vice President, Technology and Strategic Partnerships

Mr. Copa was appointed Vice President, Technology and Strategic Partnerships in October, 2012. Since joining Luminex in October, 2001, Mr. Copa has served as Director of Strategic Partner Development, Senior Director, Research Sales and Marketing, Business Unit Manager, Luminex Ag Science, and most recently as the Vice President, Luminex Life Sciences. Prior to joining Luminex, Mr. Copa was employed by Cardinal Health. While at Cardinal Health he held various positions in sales and sales management. Mr. Copa earned a B.A. from the College of Arts and Sciences, Marquette University.

Andy Ewing

Andrew D. Ewing
Vice President, Customer Experience

Mr. Ewing joined Luminex Corporation in May 2005 and currently serves as Vice President, Customer Experience. During his tenure, Mr. Ewing has held the positions of Vice President, Partner and Operations Development and Vice President, Technical Operations. Prior to joining Luminex Corporation, Mr. Ewing held management and business leadership roles as Senior Director, Customer Relations at ClearOrbit, Inc., Senior Manager of Sustaining Application Services at Dell Inc., Director of Global Support Services for 724 Solutions Inc., and Director of Operations at SCC Communications Corporation (Intrado Inc.).

scott-johnson.jpg

Scott C. Johnson, Ph.D.
Vice President, Product Development & Manufacturing

Dr. Johnson was named Vice President of Product Development & Manufacturing of our Madison, WI site following the acquisition of EraGen Biosciences in June of 2011. During his nearly 10 years with EraGen, he held leadership roles of increasing responsibility, most recently as Vice President of Product Development. Dr. Johnson's responsibilities include leadership of the MultiCode® technology and family of products. Prior to EraGen Biosciences, Dr. Johnson served in a senior technical role with CHIMERx and the USDA-National Animal Disease Center. Dr. Johnson earned a Ph.D. in Cellular and Molecular Biology at the University of Wisconsin-Madison in 1997.
 

Nancy Krunic

Nancy Krunic, Ph.D.
Vice President, Luminex Molecular Diagnostics

Dr. Krunic was appointed Vice President, Luminex Molecular Diagnostics on July 1, 2009. Previously, Dr. Krunic served as Associate Vice President, Clinical and Regulatory Affairs of Luminex Corporation. Dr. Krunic joined Luminex on March 1, 2007 through the acquisition of Tm Bioscience, where she played a key role in expanding Research & Development, Regulatory Affairs, and Quality Assurance operations to accommodate new pipeline opportunities. Prior to joining Tm, Dr. Krunic worked for five years at Leo Pharma Inc. Dr. Krunic obtained her B.Sc. and Ph.D. at the University of Toronto, Faculty of Medicine, Department of Physiology. Her academic training included affiliations with the research institutes at the Hospital for Sick Children and Mount Sinai Hospital.

Kendel Martin

Kendel B. Martin, CPA
Vice President, Accounting

Mrs. Martin joined Luminex Corporation in December 2007 and currently serves as Vice President, Accounting. In this capacity, Mrs. Martin has responsibility for Finance and Accounting, Financial Planning and Analysis and Facilities.  Previously at Luminex Corporation, Mrs. Martin held the position of Executive Director, Finance and Accounting and Director of Financial Reporting. Prior to joining Luminex Corporation, Mrs. Martin held management roles as External Reporting Manager at Freescale Semiconductor, Internal Audit Manager at Cirrus Logic and Audit Senior Manager at Ernst & Young LLP.   Mrs. Martin holds a B.A. in Economics from Rhodes College and is a Texas Certified Public Accountant.

Oliver Meek

Oliver H. Meek
Vice President, Quality Assurance and Regulatory Affairs

Mr. Meek joined Luminex Corporation in February 2000, and was appointed Vice President, Quality Assurance and Regulatory Affairs in July of 2006. He formerly served as Vice President of Manufacturing. During the 17 years prior to joining Luminex, Mr. Meek was employed at Abbott Laboratories. While at Abbott, he held various management positions in the area of Technical Product Development, Reagent and Instrument Manufacturing and Quality. Prior to joining Abbott Laboratories, he was the Technical Liaison for AMF Biological and Diagnostics Company. Mr. Meek graduated from The University of Texas at Austin in 1979 with a B.A. degree in Biology and is a Certified Quality Engineer.

 

Board of Directors

G. Walter Loewenbaum
Chairman of the Board
Executive Committee

Mr. Loewenbaum has served as a member of the board of directors since May 1995 and as Chairman of the board of directors since September 2002. Mr. Loewenbaum also has served as chairman of the board of directors of 3D Systems since September 1999, and was previously chairman of the board of directors of Envoy. He holds a B.A. from the University of North Carolina.

Mr. Loewenbaum originally became involved with Luminex as an original investor in Luminex prior to our initial public offering. As an investment banker and private equity investor, Mr. Loewenbaum has worked with multiple companies in a variety of different industries at different phases of organizational development, ranging from startup to publicly traded. He brings depth of knowledge in serving as chairman for public and private companies, building stockholder value and capital market considerations. Mr. Loewenbaum also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Patrick J. Balthrop Sr.
Executive Committee
Strategy & Development Committee
Mr. Balthrop joined Luminex in May 2004 as President and Chief Executive Officer and has served as a member of the board of directors since September 2004. He served as president of Fisher Healthcare, a Fisher Scientific International company, a manufacturer and supplier of products and services principally to the scientific and laboratory markets from 2002 to May 2004. Prior to Fisher Scientific International, Mr. Balthrop served in a number of leadership positions for over 20 years with Abbott Laboratories, a global, broad-based health care company, primarily in Abbott’s Diagnostics Division. Mr. Balthrop’s most recent positions at Abbott were as head of worldwide commercial diagnostics operations and as head of Abbott Vascular. Mr. Balthrop holds an M.B.A. from the Kellogg Graduate School of Management of Northwestern University, and a B.S. in Biology from Spring Hill College.

Robert J. Cresci
Chairman of the Nominating and Corporate Governance Committee
Audit Committee
Mr. Cresci has served as a member of the board of directors since December 1996. He has been a Managing Director of Pecks Management Partners Ltd., an investment management firm, since September 1990. Mr. Cresci currently serves on the boards of directors of j2 Global Communications, Inc., a provider of outsourced, value-added messaging and communications services and OFS Capital Corporation, a business development company. Within the past five years, Mr. Cresci has served on the board of directors of Sepracor Inc., a research-based pharmaceutical company, and SeraCare Life Sciences, Inc, a provider of a broad scope of biological products and services. Mr. Cresci holds an undergraduate degree in Engineering from the United States Military Academy at West Point and holds a M.B.A. in Finance from the Columbia University Graduate School of Business.

Mr. Cresci originally became involved with Luminex as an early investor in Luminex. Mr. Cresci has extensive experience serving on the boards of directors of private and public companies within the broader healthcare industry and brings a significant depth of knowledge in capital markets considerations. Mr. Cresci’s knowledge of the operations of public company boards is particularly useful in his current role as chairman of the Nominating and Corporate Governance Committee. Mr. Cresci also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Thomas W. Erickson
Chairman of the Executive Committee
Audit Committee
Mr. Erickson has served as a member of the board of directors since May 2004. Mr. Erickson served as our Interim President and Chief Executive Officer from September 2002 until our hiring of Mr. Balthrop in May 2004. He is currently chairman of the board of Western Dental Services, Inc., a dental practice management company, and Inmar, Inc., a reverse logistics and revenue recovery company. Previously, he served as a Senior Advisor to New Mountain Capital, LLC, a private equity firm, chairman and interim president of National Medical Health Card Systems, Inc., a pharmacy benefits manager, chairman of the board of PATHCare, Inc., an operator of long term care facilities, chairman of the board of TransHealthcare, Inc., a health care services company, chairman and interim president and chief executive officer of LifeCare Holdings, Inc., an operator of long-term acute care hospitals, and interim president and chief executive officer and director of Omega Healthcare Investors, Inc., a healthcare focused real estate investment trust. Mr. Erickson was also co-founder, president and chief executive officer of CareSelect Group, Inc., a physician practice management company. Earlier in his career, he held several management positions at American Hospital Supply Corporation. Mr. Erickson currently serves on the board of directors of American Renal Associates, a national provider of kidney dialysis services. Mr. Erickson holds a Bachelors degree from University of Iowa and an M.B.A. from Southern Methodist University.

Mr. Erickson brings to the board of directors extensive experience managing and growing healthcare industry companies, as well as significant general experience serving in leadership roles on boards and board committees of other public companies. Through his experience serving as Luminex’s Interim President and Chief Executive Officer from September 2002 until May 2004, Mr. Erickson offers to the board detailed insight into the Company’s business and management considerations. Through his substantial experience in the healthcare industry, in particular healthcare services and delivery, Mr. Erickson offers valuable insight on Luminex and its product offerings from the perspective of healthcare providers.

Fred C. Goad, Jr.
Compensation Committee
Nominating and Corporate Governance Committee
Mr. Goad has served as a member of the board of directors since September 1997. Since August 2001, he has been a member in Voyent Partners, L.L.C. (“Voyent”), a private investment company. Mr. Goad served as co-chief executive officer of the transaction services division of WebMD Corporation (“WebMD”), a provider of healthcare transaction, information and technology services, from June 2000 through March 2001. From March 1999 through May 2000, Mr. Goad served as senior advisor to the office of the president of the transaction services division of Quintiles Transnational Corporation (“Quintiles”), a contract research company providing a wide range of clinical research services for biotech and pharmaceutical clients. Mr. Goad served as co-chief executive officer and chairman of Envoy from June 1996 until Envoy was acquired by Quintiles in March 1999. From 1985 to June 1996, Mr. Goad served as president and chief executive officer of Envoy Corporation (“Envoy”), a provider of electronic transaction processing services for the healthcare industry. Within the past five years, Mr. Goad has served on the board of directors of Emageon Inc., a provider of information technology systems for hospitals, healthcare networks and imaging facilities, until its sale in 2008, Performance Food Group Company, a foodservice distributor, and on the boards of directors of several private companies. Mr. Goad holds a B.S. in business from the University of Virginia.

Mr. Goad brings to the board of directors extensive experience managing and growing healthcare industry companies, as well as significant general experience serving on boards of other public companies. Through his vast experience in the healthcare industry, in particular healthcare services and delivery, Mr. Goad offers valuable insights on Luminex and its product offerings and sales and marketing strategies from the perspective of healthcare providers. Mr. Goad also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Jay B. Johnston
Chairman of Compensation Committee
Strategy & Development Committee
Mr. Johnston has served as a member of the board of directors since February 2005. Mr. Johnston currently serves as chairman of QuesTek Innovations, LLC, a privately-held company that designs and markets high tech materials, a position he has held since August 2001. From 1975-1999, he held numerous positions at Abbott Laboratories, a global, broad-based health care company (“Abbott”), most recently as corporate vice president for diagnostic assays and systems. He held numerous other positions with Abbott, including president of Dainabot Co. Ltd. and vice president Asia Pacific. Mr. Johnston has experience in general management, product development, technology management, strategic marketing and business development. He holds an M.B.A. in General Management from the Amos Tuck School of Business Administration and a B.A. degree in Public Administration from Dartmouth College.

Mr. Johnston brings to the board of directors significant directly relevant industry experience in managing businesses in the diagnostics and life sciences industries. Mr. Johnston has extensive experience in leading the strategic and operational aspects of large complex, international organizations. Mr. Johnston’s knowledge of effective compensation processes for management helps him to guide the Company’s compensation programs and policies in his role as Chair of the Compensation Committee. Mr. Johnston also offers particular experience and perspective to the board of directors in the areas of product development and marketing strategies through his role on the Strategy and Development Committee.

Jim D. Kever
Compensation Committee
Mr. Kever has served as a member of the board of directors since December 1996. He has been a member in Voyent since August 2001. Mr. Kever served as co-chief executive officer of the transaction services division of WebMD from June 2000 to March 2001. From March 1999 through May 2000, Mr. Kever served as chief executive officer of the transaction services division of Quintiles. From August 1995 through March 1999, Mr. Kever was the president and co-chief executive officer of Envoy. Mr. Kever serves on the boards of directors 3D Systems Corporation (“3D Systems”), a provider of 3-D printing, rapid prototyping and manufacturing solutions, and Tyson Foods, Inc., a food production company (“Tyson”). Within the past five years, Mr. Kever has served on the board of directors of ACI Worldwide, Inc., a global provider of electronic payments solutions for financial institutions. Mr. Kever holds a B.S. in business administration from the University of Arkansas and a J.D. from the Vanderbilt University School of Law.

Mr. Kever brings to the board of directors extensive experience managing and growing healthcare industry companies. Mr. Kever brings experience in serving on public and private boards. Mr. Kever, through his more recent investment experiences with Voyent, also brings depth of knowledge in managing and growing companies and in capital markets considerations. Mr. Kever also brings continuity to the board of directors, given his service on the board since Luminex’s earliest years of operation.

Kevin M. McNamara
Chairman of the Audit Committee
Mr. McNamara has served as a member of the board of directors since May 2003. In addition, he provided financial and strategic consulting services to the Company from October 2001 through December 2002. Mr. McNamara served as executive vice president, chief financial officer and treasurer of HealthSpring, Inc., a managed care company, from April 2005 through May 2009. Mr. McNamara also served as non-executive chairman from April 2005 through January 2006 of MedAvant Healthcare Solutions (f/k/a ProxyMed, Inc.), a provider of automated healthcare business and cost containment solutions for financial, administrative and clinical transactions in the healthcare payments marketplace, and served as interim chief executive officer and as a director of ProxyMed, Inc. from December 2004 through June 2005. Mr. McNamara previously served as chief financial officer of HCCA International, Inc., a healthcare management and recruitment company from October 2002 to April 2005. Mr. McNamara currently serves on the board of directors of Tyson Foods, Inc., a food processing company. Within the past five years, Mr. McNamara has served on the board of directors of COMSYS IT Partners, Inc. (f/k/a Personnel Group of America, Inc.), an information technology staffing and solutions provider. Mr. McNamara is a Certified Public Accountant (inactive) and holds a B.S. in Accounting from Virginia Commonwealth University and a M.B.A. from the University of Richmond.

Mr. McNamara brings to the board of directors extensive financial expertise, experience managing and growing healthcare industry companies, as well as significant general experience serving on boards and board committees of other public companies. Mr. McNamara’s experience overseeing risk assessment, accounting and financial reporting for public and other healthcare companies provides equally valuable experience in his role as chair of our Audit Committee. Mr. McNamara also has experience overseeing public and private capital markets and mergers and acquisitions transactions.

Edward A. Ogunro, Ph.D
Strategy & Development Committee
Nominating and Corporate Governance Committee

Dr. Ogunro has served as a member of our board of directors since May 2009. Dr. Ogunro served as senior vice president, R&D and medical affairs and chief scientific officer at Hospira Inc., a global specialty pharmaceutical and medication delivery company, from April 2004 until December 2007. Prior to Abbott’s spin-off of Hospira in 2004, Dr. Ogunro served in a number of leadership positions for over 20 years with Abbott, primarily in Abbott’s Diagnostics Division, and most recently served as corporate vice president, R&D, medical and regulatory affairs in Abbott’s Hospital Products Division. He held numerous other positions with Abbott, including program director for AxSym, one of the most successful analyzers in the diagnostic industry, and divisional vice president for Abbott’s Immunodiagnostics and Chemistry R&D Organization. Dr. Ogunro currently serves on the board of directors of the Myeloproliferative Neoplasms Research Foundation (a not for profit organization.) Dr. Ogunro served on the board of directors of Applied NeuroSolutions, Inc., a company focused on the development of an integrated portfolio of products for the treatment and diagnosis of Alzheimer’s disease. Previously, Dr. Ogunro pursued postdoctoral studies and served as an assistant professor at Northwestern University Medical School in Chicago from 1977 to 1982. Dr. Ogunro holds a B.S. in Physiology and Biochemistry from Reading University and a Ph.D. in Biochemistry from London University.

Dr. Ogunro brings to the board of directors significant directly relevant technical and operational industry experience in the diagnostics and medical device industry. Dr. Ogunro has substantial experience in managing complex research and development initiatives for large, evolving portfolios of diagnostic and medical device products, and in securing and maintaining regulatory clearance for such products both domestically and internationally. Dr. Ogunro’s technical background and direct experience with project management is of particular relevance in his role on the Strategy and Development Committee and in guiding Luminex in its research and development investments on new products and markets.

back to top